IHE holdings — iShares U.S. Pharmaceuticals ETF
iShares U.S. Pharmaceuticals ETF (IHE) held 59 positions with net assets of $1.14B as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 79.5% of the fund, led by JNJ, LLY, BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares.
IHE top holdings
- JNJ JOHNSON & JOHNSON — 22.44% ($255M)
- LLY ELI LILLY AND COMPANY — 22.25% ($253M)
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24% ($71.1M)
- MRK MERCK & CO., INC. — 4.55% ($51.8M)
- BMY BRISTOL-MYERS SQUIBB COMPANY — 4.37% ($49.7M)
- RPRX ROYALTY PHARMA PLC — 4.33% ($49.3M)
- VTRS VIATRIS INC. — 4.22% ($48.0M)
- PFE PFIZER INC. — 3.96% ($45.1M)
- ZTS ZOETIS INC. — 3.73% ($42.4M)
- JAZZ JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY — 3.45% ($39.3M)
- ELAN ELANCO ANIMAL HEALTH INCORPORATED — 2.81% ($31.9M)
- AXSM AXSOME THERAPEUTICS, INC. — 2.41% ($27.5M)
- CORT CORCEPT THERAPEUTICS INCORPORATED — 1.90% ($21.6M)
- LGND LIGAND PHARMACEUTICALS INCORPORATED — 1.45% ($16.5M)
- DFTX Definium Therapeutics Inc — 1.39% ($15.8M)
- LQDA Liquidia Corp — 1.28% ($14.6M)
- INDV INDIVIOR PHARMACEUTICALS, INC. — 1.14% ($13.0M)
- Crinetics Pharmaceuticals Inc — 0.90% ($10.3M)
- OGN ORGANON & CO. — 0.81% ($9.25M)
- EWTX Edgewise Therapeutics Inc — 0.70% ($7.96M)
- AMRX AMNEAL PHARMACEUTICALS, INC. — 0.68% ($7.76M)
- ELVN Enliven Therapeutics Inc — 0.63% ($7.18M)
- SUPN SUPERNUS PHARMACEUTICALS, INC. — 0.62% ($7.02M)
- TARS Tarsus Pharmaceuticals Inc — 0.57% ($6.47M)
- MANE Veradermics Inc — 0.56% ($6.40M)
What are IHE's top 10 holdings?
JNJ (22.4%), LLY (22.2%), BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares (6.2%), MRK (4.5%), BMY (4.4%), RPRX (4.3%), VTRS (4.2%), PFE (4.0%), ZTS (3.7%), JAZZ (3.5%).
How many stocks are in IHE?
iShares U.S. Pharmaceuticals ETF reported 59 holdings as of June 30, 2026.